422 related articles for article (PubMed ID: 24530490)
1. Design, synthesis and antitubercular evaluation of novel series of N-[4-(piperazin-1-yl)phenyl]cinnamamide derivatives.
Patel KN; Telvekar VN
Eur J Med Chem; 2014 Mar; 75():43-56. PubMed ID: 24530490
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and preliminary biological evaluation of novel N-(3-aryl-1,2,4-triazol-5-yl) cinnamamide derivatives as potential antimycobacterial agents: an operational Topliss Tree approach.
Kakwani MD; Palsule Desai NH; Lele AC; Ray M; Rajan MG; Degani MS
Bioorg Med Chem Lett; 2011 Nov; 21(21):6523-6. PubMed ID: 21917452
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and antimycobacterial activity of cinnamide derivatives: a molecular hybridization approach.
Kakwani MD; Suryavanshi P; Ray M; Rajan MG; Majee S; Samad A; Devarajan P; Degani MS
Bioorg Med Chem Lett; 2011 Apr; 21(7):1997-9. PubMed ID: 21376586
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antitubercular evaluation of 4-carbonyl piperazine substituted 1,3-benzothiazin-4-one derivatives.
Peng CT; Gao C; Wang NY; You XY; Zhang LD; Zhu YX; Xv Y; Zuo WQ; Ran K; Deng HX; Lei Q; Xiao KJ; Yu LT
Bioorg Med Chem Lett; 2015 Apr; 25(7):1373-6. PubMed ID: 25754492
[TBL] [Abstract][Full Text] [Related]
5. Novel molecular hybrids of cinnamic acids and guanylhydrazones as potential antitubercular agents.
Bairwa R; Kakwani M; Tawari NR; Lalchandani J; Ray MK; Rajan MG; Degani MS
Bioorg Med Chem Lett; 2010 Mar; 20(5):1623-5. PubMed ID: 20138519
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and evaluation of diarylpiperazine derivatives as potent anti-tubercular agents.
Penta A; Franzblau S; Wan B; Murugesan S
Eur J Med Chem; 2015 Nov; 105():238-44. PubMed ID: 26498570
[TBL] [Abstract][Full Text] [Related]
7. Novel amide and sulphonamide derivatives of 6-(piperazin-1-yl)phenanthridine as potent Mycobacterium tuberculosis H37Rv inhibitors.
Naidu KM; Nagesh HN; Singh M; Sriram D; Yogeeswari P; Gowri Chandra Sekhar KV
Eur J Med Chem; 2015 Mar; 92():415-26. PubMed ID: 25590862
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and antimycobacterial activity of various 3-(4-(substitutedsulfonyl)piperazin-1-yl)benzo[d]isoxazole derivatives.
Naidu KM; Suresh A; Subbalakshmi J; Sriram D; Yogeeswari P; Raghavaiah P; Chandra Sekhar KV
Eur J Med Chem; 2014 Nov; 87():71-8. PubMed ID: 25240097
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of new cinnamic derivatives as antituberculosis agents.
De P; Koumba Yoya G; Constant P; Bedos-Belval F; Duran H; Saffon N; Daffé M; Baltas M
J Med Chem; 2011 Mar; 54(5):1449-61. PubMed ID: 21309577
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of a novel series of pseudo-cinnamic derivatives as antituberculosis agents.
Yoya GK; Bedos-Belval F; Constant P; Duran H; Daffé M; Baltas M
Bioorg Med Chem Lett; 2009 Jan; 19(2):341-3. PubMed ID: 19084396
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and evaluation of 6-(4-((substituted-1H-1,2,3-triazol-4-yl)methyl)piperazin-1-yl)phenanthridine analogues as antimycobacterial agents.
Nagesh HN; Naidu KM; Rao DH; Sridevi JP; Sriram D; Yogeeswari P; Chandra Sekhar KV
Bioorg Med Chem Lett; 2013 Dec; 23(24):6805-10. PubMed ID: 24169232
[TBL] [Abstract][Full Text] [Related]
12. Rational design, synthesis and antitubercular evaluation of novel 2-(trifluoromethyl)phenothiazine-[1,2,3]triazole hybrids.
Addla D; Jallapally A; Gurram D; Yogeeswari P; Sriram D; Kantevari S
Bioorg Med Chem Lett; 2014 Jan; 24(1):233-6. PubMed ID: 24314670
[TBL] [Abstract][Full Text] [Related]
13. 1,5-Diphenylpyrrole derivatives as antimycobacterial agents. Probing the influence on antimycobacterial activity of lipophilic substituents at the phenyl rings.
Biava M; Porretta GC; Poce G; De Logu A; Saddi M; Meleddu R; Manetti F; De Rossi E; Botta M
J Med Chem; 2008 Jun; 51(12):3644-8. PubMed ID: 18494459
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vitro antitubercular evaluation of novel sansanmycin derivatives.
Li YB; Xie YY; Du NN; Lu Y; Xu HZ; Wang B; Yu Y; Liu YX; Song DQ; Chen RX
Bioorg Med Chem Lett; 2011 Nov; 21(22):6804-7. PubMed ID: 21982497
[TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis and Antimycobacterial Activity of Novel Imidazo[1,2-a]pyridine Amide-Cinnamamide Hybrids.
Li L; Li Z; Liu M; Shen W; Wang B; Guo H; Lu Y
Molecules; 2015 Dec; 21(1):E49. PubMed ID: 26729085
[TBL] [Abstract][Full Text] [Related]
16. Novel 2-(2-benzylidenehydrazinyl)benzo[d]thiazole as potential antitubercular agents.
Bairwa VK; Telvekar VN
Comb Chem High Throughput Screen; 2013 Mar; 16(3):244-7. PubMed ID: 23176058
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antitubercular screening of [(2-chloroquinolin-3-yl)methyl] thiocarbamide derivatives.
Kumar S; Upmanyu N; Afzal O; Bawa S
Chem Biol Drug Des; 2014 Nov; 84(5):522-30. PubMed ID: 24750991
[TBL] [Abstract][Full Text] [Related]
18. New class of methyl tetrazole based hybrid of (Z)-5-benzylidene-2-(piperazin-1-yl)thiazol-4(%H)-one as potent antitubercular agents.
Chauhan K; Sharma M; Trivedi P; Chaturvedi V; Chauhan PM
Bioorg Med Chem Lett; 2014 Sep; 24(17):4166-70. PubMed ID: 25127167
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and Spectrum of Biological Activities of Novel N-arylcinnamamides.
Pospisilova S; Kos J; Michnova H; Kapustikova I; Strharsky T; Oravec M; Moricz AM; Bakonyi J; Kauerova T; Kollar P; Cizek A; Jampilek J
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30087309
[No Abstract] [Full Text] [Related]
20. Novel fluoroquinolones: design, synthesis, and in vivo activity in mice against Mycobacterium tuberculosis H37Rv.
Shindikar AV; Viswanathan CL
Bioorg Med Chem Lett; 2005 Apr; 15(7):1803-6. PubMed ID: 15780610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
